来自MSN55 分钟
Mineralys Therapeutics Receives FDA Clearance for Phase 2 Trial of Lorundrostat in Treating ...
Mineralys Therapeutics, Inc. has announced that the U.S. Food and Drug Administration (FDA) has approved its Investigational ...